Study identifier:NIS-RFR-DUM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Factors determining quality of life related to respiratory status according to gender of COPD patients followed by a pneumologist
Chronic Obstructive Pulmonary Disease
-
No
-
All
449
Observational
18 Years +
Allocation: - 
Endpoint Classification: - 
Intervention Model: - 
Masking: - 
Primary Purpose: - 
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
| Arms | Assigned Interventions | 
|---|---|
| 1 | - |